COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
INTRASENSE : DUOnco™ Pancreas CE marking: a key innovation for the early detection of pancreactic cancer using AI
Intrasense obtains CE marking under MDR for DUOnco™ Pancreas, an AI solution enhancing early detection of pancreatic cancer. CEO Alexandre Salvador highlights the innovation's importance in clinical practice and patient care -
COMMUNIQUÉ DE PRESSE
INTRASENSE : Certification CE de DUOnco™ Pancreas : une innovation clé pour la détection précoce du cancer du pancréas par IA
Intrasense obtient la certification CE de DUOnco™ Pancreas, une solution par IA pour la détection précoce du cancer du pancréas, renforçant son avance technologique en oncologie -
-
COMMUNIQUÉ DE PRESSE
Transformation with prospects: Varengold Bank uses 2024 annual financial statements to tidy up and resolutely continues its realignment
Varengold Bank AG reports balanced result before taxes for 2024 financial year, with net income down 23% year-on-year. New management focuses on risk management and future growth opportunities -
-
COMMUNIQUÉ DE PRESSE
Apple Devices Propel RI Availability to Over 5B Worldwide - ReelTime’s Reel Intelligence Leads in Potential Reach, Capability, and Sustainability
ReelTime Media's Reel Intelligence (RI) extends to Apple devices, reaching over 1.38 billion iPhones and 670 million iPads globally. RI offers high-performance AI without data centers, outperforming competitors -
COMMUNIQUÉ DE PRESSE
Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Aspire's BUZZ BOMB™ sublingual pre-workout supplement with 50mg of caffeine in four flavors showcased at FitCon and FitExpo, impressing fitness experts and consumers for its rapid delivery technology and convenience -
-
